Jamp Pharma Group
↗Boucherville, Canada
Jamp Pharma Group is a privately owned Canadian pharmaceutical company based in Boucherville, Quebec. It is one of the fastest-growing pharmaceutical companies in Canada, specializing in the development, manufacturing, and distribution of generic drugs. The company offers a massive portfolio of over 300 products across nearly all therapeutic areas.
Beyond generics, Jamp Pharma has expanded significantly into biosimilars through its specialized division, Orbeo, and provides branded specialty products and vitamins. The company operates a state-of-the-art 154,000-square-foot facility in Canada and maintains a significant R&D and regulatory presence in India to support its global supply chain.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic Pharmaceuticals & Biosimilars
SIZE & FINANCIALS
Employees:501-1000
Revenue:$300M-$500M
Founded:1988
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Investors:Louis Pilon (Owner), Investissement Québec
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biosimilars, Injectables, Oral solids
Active Trials:2
Trial Phases:Phase 1: 1 | Phase 3: 1
FDA Approvals:15
EMA Approvals:5
CORPORATE STRUCTURE
Subsidiaries:Orbeo (Biosimilars), Laboratoire Jamp, Wampole
Key Partnerships:Alvotech (Biosimilar partnership), Celltrion (Distribution agreements)
COMPETITION
Position:Leader
Competitors:Apotex, Teva Canada, Sandoz Canada, Pharmascience
LEADERSHIP
Key Executives:
Louis Pilon - President & CEO
Bruno Mader - Chief Operating Officer
Scientific Founders:Louis Pilon
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Jamp Pharma Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Jamp Pharma Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.